Assembly Bill A6799B

2023-2024 Legislative Session

Establishes a drug-induced movement disorder screening education program

download bill text pdf

Sponsored By

Current Bill Status - Passed Senate & Assembly


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

2023-A6799 - Details

See Senate Version of this Bill:
S8965
Law Section:
Public Health Law
Laws Affected:
Amd §207, Pub Health L

2023-A6799 - Summary

Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.

2023-A6799 - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6799
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                May 8, 2023
                                ___________
 
 Introduced by M. of A. PAULIN -- read once and referred to the Committee
   on Health
 
 AN  ACT  to  amend  the public health law, in relation to establishing a
   drug-induced movement disorder screening education program
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section  1.  The  public health law is amended by adding a new article
 2-C to read as follows:
                                 ARTICLE 2-C
                 DRUG-INDUCED MOVEMENT DISORDER SCREENING
                             EDUCATION PROGRAM
 SECTION 295. DRUG-INDUCED MOVEMENT DISORDER SCREENING EDUCATION PROGRAM.
   § 295. DRUG-INDUCED MOVEMENT DISORDER SCREENING EDUCATION PROGRAM.  1.
 THERE  IS HEREBY ESTABLISHED IN THE DEPARTMENT, IN CONSULTATION WITH THE
 OFFICE OF MENTAL HEALTH,  A  DRUG-INDUCED  MOVEMENT  DISORDER  SCREENING
 EDUCATION  PROGRAM.  THE  PURPOSE OF THE PROGRAM SHALL BE TO EDUCATE THE
 PUBLIC, HEALTHCARE PROFESSIONALS, MENTAL  HEALTH  PROFESSIONALS,  PUBLIC
 SAFETY  OFFICIALS,  AND  PUBLIC HEALTH OFFICIALS ABOUT THE IMPORTANCE OF
 SCREENING FOR DRUG-INDUCED MOVEMENT DISORDERS, DEVELOP GUIDANCE ON CLIN-
 ICAL STANDARDS FOR TREATING DRUG-INDUCED MOVEMENT DISORDERS, AND  ELIMI-
 NATE  BIAS  AND  REDUCTION OF STIGMA FOR PEOPLE LIVING WITH DRUG-INDUCED
 MOVEMENT DISORDERS RELATED TO THE TREATMENT OF MENTAL HEALTH CONDITIONS.
   2. FOR PURPOSES OF THIS SECTION, THE FOLLOWING TERMS  SHALL  HAVE  THE
 FOLLOWING MEANINGS:
   (A)  "DRUG-INDUCED MOVEMENT DISORDERS" MEANS A RANGE OF DRUG REACTIONS
 CHARACTERIZED  BY  INVOLUNTARY  OR  OTHERWISE  ABNORMAL  MOTOR  FUNCTION
 INCLUDING,  BUT  NOT  LIMITED TO, TARDIVE DYSKINESIA, MEDICATION-INDUCED
 PARKINSONISM, NEUROLEPTIC MALIGNANT SYNDROME,  MEDICATION-INDUCED  ACUTE
 DYSTONIA,  MEDICATION-INDUCED  ACUTE  AKATHISIA,  TARDIVE AKATHISIA, AND
 MEDICATION-INDUCED POSTURAL TREMOR.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10964-01-3
 A. 6799                             2
              

co-Sponsors

2023-A6799A - Details

See Senate Version of this Bill:
S8965
Law Section:
Public Health Law
Laws Affected:
Amd §207, Pub Health L

2023-A6799A - Summary

Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.

2023-A6799A - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  6799--A
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                May 8, 2023
                                ___________
 
 Introduced by M. of A. PAULIN -- read once and referred to the Committee
   on  Health -- committee discharged, bill amended, ordered reprinted as
   amended and recommitted to said committee
 
 AN ACT to amend the public health law, in  relation  to  establishing  a
   drug-induced movement disorder screening education program

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 1 of section 207 of the public  health  law  is
 amended by adding a new paragraph (h) to read as follows:
   (H)  THE  DEPARTMENT  SHALL  DEVELOP  AND CONDUCT A PROGRAM CONCERNING
 DRUG-INDUCED MOVEMENT DISORDERS. SUCH PROGRAM SHALL INCLUDE BUT  NOT  BE
 LIMITED  TO,  (I) EDUCATIONAL INFORMATION ON THE IMPORTANCE OF SCREENING
 FOR AND IDENTIFYING SYMPTOMS OF  DRUG-INDUCED  MOVEMENT  DISORDERS;  AND
 (II)  THE  DEVELOPMENT  OF  GUIDANCE  ON CLINICAL STANDARDS FOR TREATING
 DRUG-INDUCED MOVEMENT DISORDERS, INCLUDING  FOR  SERVICES  PROVIDED  VIA
 TELEHEALTH.  SUCH  PROGRAM  SHALL ALSO INCLUDE EDUCATION AND OUTREACH ON
 THE ELIMINATION OF STIGMA FOR PEOPLE LIVING WITH  DRUG-INDUCED  MOVEMENT
 DISORDERS RELATED TO THE TREATMENT OF MENTAL HEALTH CONDITIONS.
   §  2.  This  act shall take effect on the ninetieth day after it shall
 have become a law. Effective immediately, the addition, amendment and/or
 repeal of any rule or regulation necessary  for  the  implementation  of
 this  act  on its effective date are authorized to be made and completed
 on or before such effective date.
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10964-02-3



              

co-Sponsors

2023-A6799B (ACTIVE) - Details

See Senate Version of this Bill:
S8965
Law Section:
Public Health Law
Laws Affected:
Amd §207, Pub Health L

2023-A6799B (ACTIVE) - Summary

Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.

2023-A6799B (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  6799--B
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                May 8, 2023
                                ___________
 
 Introduced  by  M.  of  A.  PAULIN,  SAYEGH,  SEAWRIGHT -- read once and
   referred to the Committee on  Health  --  committee  discharged,  bill
   amended,  ordered reprinted as amended and recommitted to said commit-
   tee -- recommitted to the  Committee  on  Health  in  accordance  with
   Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered
   reprinted as amended and recommitted to said committee
 
 AN  ACT  to  amend  the public health law, in relation to establishing a
   drug-induced movement disorder screening education program
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Subdivision  1 of section 207 of the public health law is
 amended by adding a new paragraph (h) to read as follows:
   (H) THE DEPARTMENT SHALL DEVELOP  AND  CONDUCT  A  PROGRAM  CONCERNING
 DRUG-INDUCED  MOVEMENT  DISORDERS. SUCH PROGRAM SHALL INCLUDE BUT NOT BE
 LIMITED TO, (I) EDUCATIONAL INFORMATION ON THE IMPORTANCE  OF  SCREENING
 FOR  AND  IDENTIFYING  SYMPTOMS  OF DRUG-INDUCED MOVEMENT DISORDERS; AND
 (II) THE DEVELOPMENT AND  DISSEMINATION  OF  EDUCATIONAL  MATERIALS  FOR
 HEALTHCARE  PROVIDERS  REGARDING  TREATMENT  FOR  DRUG-INDUCED  MOVEMENT
 DISORDERS, INCLUDING FOR SERVICES PROVIDED VIA TELEHEALTH.  SUCH  EDUCA-
 TIONAL MATERIALS DISSEMINATED TO HEALTHCARE PROVIDERS SHALL BE DEVELOPED
 AND  DISSEMINATED  IN  COORDINATION  WITH  RELEVANT  HEALTHCARE PROVIDER
 GROUPS AND SHALL INCLUDE BEST PRACTICES FOR THE TREATMENT AND  SCREENING
 OF  MOVEMENT  DISORDERS INFORMED BY THE AMERICAN PSYCHIATRIC ASSOCIATION
 AND OTHER PROFESSIONAL SOCIETY PRACTICE GUIDELINES.  SUCH PROGRAM  SHALL
 ALSO  INCLUDE  EDUCATION  AND  OUTREACH ON THE ELIMINATION OF STIGMA FOR
 PEOPLE LIVING WITH DRUG-INDUCED MOVEMENT DISORDERS RELATED TO THE TREAT-
 MENT OF MENTAL HEALTH CONDITIONS.
   § 2. This act shall take effect on the ninetieth day  after  it  shall
 have become a law. Effective immediately, the addition, amendment and/or
 repeal  of  any  rule  or regulation necessary for the implementation of
 this act on its effective date are authorized to be made  and  completed
 on or before such effective date.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.